Nutracaps

Investigation of Nanoencapsulated Bioactive Compounds for Healthy Nutrition.

This strategic project proposes an innovative solution to address the challenges of Metabolic Syndrome and wound healing, based on natural bioactives such as omega-6 fatty acids and quercetin, compounds recognized for their anti-inflammatory properties, ability to reduce insulin resistance, and skin-repairing effects.

The project combines health and sustainability through the co-encapsulation of natural bioactives in food-grade nanoparticles, enhancing their efficacy and bioavailability. Additionally, it promotes the use of agro-food byproducts from Navarra and new natural sources like blackcurrant, aligning with circular economy principles.

NUTRACAPS includes advanced in vitro and in vivo studies, as well as evaluating applicability in various food, nutraceutical, and dermaceutical matrices, assessing their stability, safety, and economic viability.

Title: NUTRACAPS
Identification Number: 0011-1411-2025-000158
Execution Period: April 2025–December 2027
Executing Entities: NUCAPS, Iberfruta, Isanatur, Ingredalia, Ojer Pharma, Espiga I+D, UNAV, CNTA, NAGRIFOOD

This company has received funding co-financed at 40% by the European Regional Development Fund through the Navarre ERDF Operational Programme 2021–2027.